(E)-(6R,7R)-7-Amino-3-(1-naphthalen-2-yl-2-oxo-pyrrolidin-3-ylidenemethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid trifluoroacetate | 188536-68-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: (E)-(6R,7R)-7-Amino-3-(1-naphthalen-2-yl-2-oxo-pyrrolidin-3-ylidenemethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid trifluoroacetate
• 英文别名: (6R,7R)-7-amino-3-[(E)-(1-naphthalen-2-yl-2-oxopyrrolidin-3-ylidene)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;2,2,2-trifluoroacetic acid
• CAS: 188536-68-7
• 化学式: C₂HF₃O₂*C₂₂H₁₉N₃O₄S
• 分子量: 535.501
• InChiKey: AMOXZFDXJPMDKE-POARNCAISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.72
• 重原子数：
  37
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  167
• 氢给体数：
  3
• 氢受体数：
  11

文献信息

• Cephalosporin derivatives
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP0761673A1

  公开（公告）日：1997-03-12

  The present invention relates to cephalosporin derivatives of the general formula I wherein R1is a group selected from 2-, 3- and 4-hydroxyphenyl, 2- and 3-methoxyphenyl, 4-carboxyphenyl, 4-carbamoylphenyl, 3-trifluoromethylphenyl, 2- and 3-fluorophenyl, 3-nitrophenyl, 3-fluoro-4-hydroxyphenyl, 2-fluoro-4-hydroxyphenyl, 3-fluoro-2-hydroxyphenyl, 3-, 4-dihydroxyphenyl, benzyl, -CHR-phenyl, 3-hydroxybenzyl, 4-aminobenzyl, 2-, 3- and 4-fluorobenzyl, 2-, 3- and 4-methoxybenzyl, 4-nitrobenzyl, 4-carboxybenzyl, 4-trifluoromethylbenzyl, 1-naphthyl and 2-naphthyl, all hydroxy, amino, carboxy and carbamoyl substituents optionally being substituted, or is pyridinyl mono-substituted with halogen, pyrimidyl, pyrazinyl di-substituted with lower alkyl, pyridazinyl mono-substituted with halogen, piperidinyl in which the amino group may be substituted by an acyl group, thiadiazolyl, oxo-tetrahydrofuranyl, thiophenyl mono-substituted with lower alkoxycarbonyl or carbamoyl, tetrazolyl-lower alkyl, tetrahydrofuranyl-lower alkyl, thiophenyl-lower alkyl or benzimidazolyl-lower alkyl; and Ris carboxy or esterified carboxy; readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts, as well as the their use and the process for manufacturing such compounds.

  本发明涉及公式I的头孢菌素衍生物，其中R1是从2-、3-和4-羟基苯基、2-和3-甲氧基苯基、4-羧基苯基、4-氨基甲酰基苯基、3-三氟甲基苯基、2-和3-氟苯基、3-硝基苯基、3-氟-4-羟基苯基、2-氟-4-羟基苯基、3-氟-2-羟基苯基、3-、4-二羟基苯基、苄基、-CHR-苯基、3-羟基苄基、4-氨基苄基、2-、3-和4-氟苄基、2-、3-和4-甲氧基苄基、4-硝基苄基、4-羧基苄基、4-三氟甲基苄基、1-萘基和2-萘基中选择的基团，所有羟基、氨基、羧基和氨甲酰基取代基均可取代，或是单卤代的吡啶基、嘧啶基、二取代的吡嗪基、单卤代的吡嗪基、哌啶基，其中氨基基团可以被酰基取代，噻二唑基、氧代四氢呋喃基、单取代的噻吩基，取代基为低碳基氧羰基或氨甲酰基，四氮唑基-低碳基，四氢呋喃基-低碳基，噻吩基-低碳基或苯并咪唑基-低碳基；和R是羧基或酯化羧基；这些化合物的容易水解的酯，其药学上可接受的盐以及公式I和其酯和盐的化合物的水合物，以及它们的使用和制造这些化合物的过程。